Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells

Journal of Ethnopharmacology

Volumn 115, Issue 3, 2007, Pages 455-462

  Choy, Cheuk Sing ^a,b   Hu, Chien Ming ^a,b   Chiu, Wen Ta ^a   Lam, Carlos Shu Kei ^a   Ting, Yih ^a   Tsai, Shin Han ^a   Wang, Tzu Chien ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cyclooxygenase 2; Inducible nitric oxide synthase; Lipopolysaccharide; Nuclear factor B; Sanguis Draconis

Indexed keywords

CYCLOOXYGENASE 2; DAEMOMORPOPS DRACO EXTRACT; HEME OXYGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PLANT EXTRACT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DAEMOMORPOPS DRACO; DRUG EFFECT; ENZYME INHIBITION; MEDICINAL PLANT; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ARECACEAE; DRACO;

EID: 37349053781     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.10.012     Document Type: Article

References (34)

1. Baeuerle P.A. IκB-NF-κB structures: at the interface of inflammation control. Cell 95 (1998) 729-731
2. Baeuerle P.A., and Baltimore D. NF-κB: ten years after. Cell 87 (1996) 13-20
3. Baldwin Jr. A.S. The NF-κB and IκB proteins: new discoveries and insights. Annual Review of Immunology 14 (1996) 649-683
4. Chen F., Demers L.M., and Shi X. Upstream signal transduction of NF-κB activation. Current Drug Targets. Inflammation and Allergy 1 (2002) 137-149
5. Chen H.H., Sun C.C., Tseng M.P., and Hsu C.J. A patch test study of 27 crude drugs commonly used in Chinese topical medicaments. Contact Dermatitis 49 (2003) 8-14
6. 2 augments IL-10 signaling and function. Journal of Immunology 15 (2006) 1092-1100
7. Di Rosa M., Lalenti A., Ianaro A., and Sautebin L. Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukocyte Essentail Fatty Acids 54 (1996) 229-238
8. DiGirolamo G., Farina M., Riberio M.L., Ogando D., Aisemberg J., Santos A.R., de los., Marti M.L., and Franchi A.M. Effects of cyclooxygenase inhibitor pretreatment on nitric oxide production, nNOS and iNOS expression in rat cerebellum. British Journal of Pharmacology 139 (2003) 1164-1170
9. Dobrovolskaia M.A., and Vogel S.N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes and Infection 4 (2002) 903-914
10. Edwards H.G.M., Oliveira L.F.C., and Prendergast H.D.V. Raman spectroscopic analysis of dragon's blood resins-basis for distinguishing between Dracaena (Convallariaceae), Daemonorops (Palmae) and Croton (Euphorbiaceae). Analyst 129 (2004) 134-138
11. Exner M., Minar E., Wagner O., and Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radical Biology & Medicine 37 (2004) 1097-1104
12. Ghosh S., and Karin M. Missing pieces in the NF-κB puzzle. Cell 109 (2002) 81-96
13. 15N]nitrate in biological fluids. Analytical Biochemistry 126 (1982) 131-138
14. Gurgel L.A., Sidrim J.J., Martins D.T., Cechinel Filho V., and Rao V.S. In vitro antifungal activity of dragon's blood from Croton urucurana against dermatophytes. Journal of Ethnopharmacology 97 (2001) 409-412
15. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends in Immunology 23 (2002) 144-150
16. Jarrar D., Kuebler J.F., Rue L.W., Matalon S., Wang P., Bland K.I., and Chaudry I.H. Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-κB and MAPK/ERK mechanisms. America Journal of Physiology. Lung Cellular and Molecular Physiology 283 (2002) L799-L805
17. Jones K. Review of sangre de drago (Croton lechleri)-a South American tree sap in the treatment of diarrhea, inflammation, insect bites, viral infections, and wounds: traditional uses to clinical research. Journal Alternative and Complementary Medicine 9 (2003) 877-896
18. Kleinert H., Pautz A., Linker K., and Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. European Journal of Pharmacology 500 (2004) 255-266
19. Lu H., Teng J., and Wu H. A review on the study of Resina Draconis produced in China. Journal of Chinese Medicinal Materials 26 (2003) 459, 461
20. Mariathasan S., and Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nature Reviews Immunology 7 (2007) 31-40
21. Marletta M.A. Nitric oxide synthase structure and mechanism. The Journal of Biological Chemistry 268 (1993) 12231-12234
22. McCann S.M., Mastronardi C., Laurentiis A.de., and Rettori V. The nitric oxide theory of aging revisited. Annals of the New York Academy of Sciences 1057 (2005) 64-84
23. Peres M.T.L.P., Delle Monache F., Cruz A.B., Pizzolatti M.G., and Yunes R.A. Chemical composition and antimicrobial activity of Croton urucurana Baillon (Euphorbiaceae). Journal of Ethnopharmacology 56 (1997) 223-226
24. Pokharel Y.R., Yang J.W., Kim J.Y., Oh H.W., Jeong H.G., Woo E.R., and Kang K.W. Potent inhibition of the inductions of inducible nitric oxide synthase and cyclooxygenase-2 by taiwaniaflavone. Nitric Oxide 15 (2006) 217-225
25. Rahman I., Biswas S.K., and Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical Pharmacology 72 (2006) 1439-1452
26. Rao V.S., Gurgel L.A., Lima-Júnior R.C., Martins D.T., Cechinel-Filho V., and Santos F.A. Dragon's blood from Croton urucurana (Baill.) attenuates visceral nociception in mice. Journal of Ethnopharmacology 113 (2007) 357-360
27. Selmi C., Mao T.K., Keen C.L., Schmitz H.H., and Eric G.M. The anti-inflammatory properties of cocoa flavanols. Journal of Cardiovascular Pharmacology 47 (2006) S163-S171
28. Tanaka A., Hase S., Miyazawa T., Ohno R., and Takeuchi K. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. The Journal of Pharmacology and Experimental Therapeutics 303 (2002) 1248-1254
29. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., and Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proceedings of the National Academy of Sciences of the United States of America 91 (1994) 2046-2050
30. Verstak B., Hertzog P., and Mansell A. Toll-like receptor signalling and the clinical benefits that lie within. Inflammation Research 56 (2007) 1-10
31. Wolf A.M., Wolf D., Rumpold H., Ludwiczek S., Enrich B., Gastl G., Weiss G., and Tilg H. The kinase inhibitor imatinib mesylate inhibits TNF-α production in vitro and prevents TNF-dependent acute hepatic inflammation. Proceedings of the National Academy of Sciences of the United States of America 20 (2005) 13622-13627
32. Wright S.D. Toll, a new piece in the puzzle of innate immunity. The Journal of Experimental Medicine 189 (1999) 605-609
33. Zedler S., and Faist E. The impact of endogenous triggers on trauma-associated inflammation. Current Opinim in Critical Care 12 (2006) 595-601
34. Zhang G., and Ghosh S. Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors. Journal of Endotoxin Research 6 (2000) 453-457